ArticleOncotarget2018

Targeting protein kinase CK2 and CDK4/6 pathways with a multi-kinase inhibitor ON108110 suppresses pro-survival signaling and growth in mantle cell lymphoma and T-acute lymphoblastic leukemia.

Amol Padgaonkar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.